Topics:
Arthritis|Imaging In Rheumatology|Lupus|Psoriatic Arthritis|Women's Health And Rheumatology|Geriatrics|Gout|Browse All Topics

Rheumatology Network

Thumbs Up for Hyaluronic Acid Injections?

The latest assessment of the controversial injections for knee osteoarthritis deems them effective, and even superior to acetaminophen. What can you believe? An expert on osteoarthritis weighs in..

Recent Content

First Step Toward Knee OA Progression: Pain on Stairs

Rita Baron-Faust
January 27, 2015 | Osteoarthritis, Arthritis, Musculoskeletal Citations
By

Data from a large sample of patients with knee osteoarthritis shows a common pattern in the onset of knee pain.

64-Year-Old Man With Draining Wounds on His Toes

Norman Bauman
January 26, 2015 | Gout, Musculoskeletal Citations
By

All of the signs pointed to osteomyelitis with sepsis. But further examination pointed to consequences of poorly controlled gout.

New Classification System for SLE May Aid Earlier Diagnosis

Rita Baron-Faust
News | January 23, 2015 | Lupus, Musculoskeletal Citations
By

The new SLICC 2012 classification criteria are far more sensitive in real-life clinical practice than the ACR97 lupus criteria, especially within the first 5 years of onset.

New Rheumatology Journal Club Launching on Twitter

Lois Wingerson
News | January 23, 2015 | Musculoskeletal Citations, Rheumatic Diseases
By

A new online journal club, RheumJC, launches with two live chats on Twitter on January 29. It's the first journal club ever in rheumatology, an opportunity for rheumatologists worldwide to discuss important published research.

amyopathic dermatomyositis

Dermatomyositis, DVT, and D-Dimer

Norman Bauman
January 22, 2015 | Myositis
By

Pulmonary embolism and deep vein thrombosis developed in a 40-year-old man with amyopathic dermatomyositis. D-dimer levels were a red flag.

FDA Approves IL-17 Blocker Secukinumab for Plaque Psoriasis

Lois Wingerson
News | January 22, 2015 | Psoriatic Arthritis
By

The US Food and Drug Administration (FDA) has approved the interleukin 17A inhibitor secukinumab (Cosentyx) for adults with moderate to severe plaque psoriasis.  

Why Apps Aren't Applicable for Rheumatology (Yet)

Lois Wingerson
News | January 21, 2015 | Rheumatic Diseases, Rheumatoid Arthritis, Rheumatologic Pain
By

The FDA has decided will not regulate health apps designed to collect disease information. They're not ready to be useful for rheumatology. Nonetheless, your patients are undoubtedly using them.

View More Videos
View More Podcasts

By clicking Accept, you agree to become a member of the UBM Medica Community.